孤儿药物报告 2013.pdfVIP

Orphan Drug repOrt 2013 april 2013 Welcome to the evaluatepharma® Orphan Drug report 2013 ® The first edition of EvaluatePharma ’s Orphan Drug Report brings together many of our analyses to provide top-level insight, from the world’s financial markets, into the expected performance of the orphan drug market between now and 2018. Based on EvaluatePharma® ’s coverage of over 4,000 of the world’s